TRAIL-Expressing Gingival-Derived Mesenchymal Stem Cells Inhibit Tumorigenesis of Tongue Squamous Cell Carcinoma
Authors:
- 12 November 2014
- journal article
- research article
- Published by SAGE Publications in Journal of Dental Research
- Vol. 94 (1) , 219-228
Abstract
Recent research has verified that mesenchymal stromal/stem cells (MSCs) derived from bone marrow or adipose tissues can migrate toward a variety of tumors. In this study, we explored whether human gingival-derived MSCs (G-MSCs) can migrate toward tongue squamous cell carcinoma (TSCC) and evaluated the antitumor effect of engineered G-MSCs in expressing and delivering the tumor necrosis factor–related apoptosis-inducing ligand (TRAIL). An in vitro cell migration assay with Transwell plates showed that human G-MSCs can migrate toward TSCC cell lines (Tca8113 and Cal27). Then, human G-MSCs, as a type of cell-based vehicle, were transduced with full-length TRAIL and enhanced green fluorescent protein reporter genes by the lentivirus (LV) system (G-MSCs with full-length TRAIL; G-MSCFLT). Tca8113 and Cal27 were co-cultured with G-MSCFLT, respectively, to evaluate the function of G-MSCFLT on tumor cells in vitro. This resulted in G-MSCFLT’s inducing a great number of tumor cell necrosis and apoptosis. Meanwhile, in vivo antitumor assays were performed by administering G-MSCFLT to nude mice locally and systematically (mixed injection with tumor cells and tail vein injection). This showed that G-MSCFLT can reduce or even inhibit TSCC growth regardless of the method of administration, especially when the mixed injection of tumor cells and G-MSCFLT was at a ratio of 1:1, which showed no tumor formation. Furthermore, this verified that G-MSCFLT migrated toward TSCC in quantity. These data emphasize the effectiveness of G-MSCs as a vehicle for cell-based gene therapy and the antitumor activity of TRAIL-expressing G-MSCs.Keywords
This publication has 30 references indexed in Scilit:
- In vitro anti‐myeloma activity of TRAIL‐expressing adipose‐derived mesenchymal stem cellsBritish Journal of Haematology, 2012
- Stable expression of native Coagulation factor VIII using the 2A self-processing sequence and furin cleavage siteThrombosis Research, 2011
- Bone marrow-derived mesenchymal stem cells and the tumor microenvironmentCancer and Metastasis Reviews, 2010
- Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent ImagingStem Cells, 2009
- Adult Stromal Cells Derived from Human Adipose Tissue Provoke Pancreatic Cancer Cell Death both In Vitro and In VivoPLOS ONE, 2009
- Molecular Pathogenesis of Oral Squamous Cell Carcinoma: Implications for TherapyJournal of Dental Research, 2008
- Mesenchymal stem cells within tumour stroma promote breast cancer metastasisNature, 2007
- Earlier Onset of Syngeneic Tumors in the Presence of Mesenchymal Stem CellsTransplantation, 2006
- Human Fetal Mesenchymal Stem Cells as Vehicles for Gene DeliveryStem Cells, 2005
- Safety and antitumor activity of recombinant soluble Apo2 ligandJournal of Clinical Investigation, 1999